A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice - PubMed (original) (raw)
. 1998 May 15;160(10):4822-30.
Affiliations
- PMID: 9590229
A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice
M Falcone et al. J Immunol. 1998.
Abstract
Experimental allergic encephalomyelitis (EAE) is a T cell-mediated autoimmune disease of the central nervous system (CNS) that has served as the principal experimental model for multiple sclerosis (MS). Susceptibility to disease is thought to correlate with the ability to generate a Th1-type cytokine profile in myelin-responsive T cells, whereas T cells producing a Th2 cytokine pattern, in particular IL-4, are thought to be nonencephalitogenic and also to confer protection against a Th1-type response. However, recent studies using a variety of genetically engineered animals in which the genes for Th1-type cytokines and/or their receptors have been inactivated have called into question the Th1-Th2 paradigm in experimental allergic encephalomyelitis. In this report we have addressed the contribution of IL-4 to disease expression by studying two strains of mice, C57BL/6 and BALB/c, in which the gene for IL-4 has been inactivated. The IL-4-deficient C57BL/6 mice, and to a lesser extent the IL-4-deficient BALB/c mice, developed a more severe form of clinical disease, a more extensive pathologic involvement of the spinal cord, and an increased expression of proinflammatory cytokines in the CNS than their wild-type littermates. BALB/c and C57BL/6 mice showed a slightly different cytokine profile in the CNS. Both groups of animals recovered from the acute clinical episode in a time frame that was essentially identical to that found in the wild-type controls. We conclude that IL-4 plays an important role in modulating the severity of the encephalitogenic process, but does not by itself contribute to spontaneous remission from the disease.
Similar articles
- IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. Bettelli E, et al. J Immunol. 1998 Oct 1;161(7):3299-306. J Immunol. 1998. PMID: 9759845 - Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL. Jee Y, et al. Int Immunol. 2006 Apr;18(4):537-44. doi: 10.1093/intimm/dxh394. Epub 2006 Feb 15. Int Immunol. 2006. PMID: 16481342 - [Cell therapy and its risks].
Bohl JR, Goebel HH, Pötsch L, Walther G, Mattern R. Bohl JR, et al. Fortschr Med. 1994 Jun 30;112(18):261-5. Fortschr Med. 1994. PMID: 8088690 Review. German. - Interleukin-4-deficient mice.
Müller W, Rajewsky K, Kühn R. Müller W, et al. Res Immunol. 1993 Oct;144(8):637-8. doi: 10.1016/s0923-2494(05)80018-5. Res Immunol. 1993. PMID: 8303082 Review. No abstract available.
Cited by
- The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis.
Dadfar S, Yazdanpanah E, Pazoki A, Nemati MH, Eslami M, Haghmorad D, Oksenych V. Dadfar S, et al. Cells. 2024 Sep 16;13(18):1556. doi: 10.3390/cells13181556. Cells. 2024. PMID: 39329740 Free PMC article. Review. - The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology.
Amoriello R, Memo C, Ballerini L, Ballerini C. Amoriello R, et al. Mol Brain. 2024 Jan 23;17(1):4. doi: 10.1186/s13041-024-01077-7. Mol Brain. 2024. PMID: 38263055 Free PMC article. Review. - Interleukin-4 Plasma Levels Stratified by Sex in Intermediate Age-Related Macular Degeneration and Geographic Atrophy.
Rajeswaren V, Wagner BD, Patnaik JL, Mandava N, Mathias MT, Manoharan N, De Carlo Forest TE, Gnanaraj R, Lynch AM, Palestine AG; University of Colorado Retina Research Group. Rajeswaren V, et al. Transl Vis Sci Technol. 2023 Aug 1;12(8):1. doi: 10.1167/tvst.12.8.1. Transl Vis Sci Technol. 2023. PMID: 37526620 Free PMC article. - Type 2 immunity in the brain and brain borders.
Mamuladze T, Kipnis J. Mamuladze T, et al. Cell Mol Immunol. 2023 Nov;20(11):1290-1299. doi: 10.1038/s41423-023-01043-8. Epub 2023 Jul 10. Cell Mol Immunol. 2023. PMID: 37429945 Free PMC article. Review. - Treatment of autoimmune encephalomyelitis with a histone deacetylase inhibitor.
Jayaraman AK, Avgush K, Kulam R, Soni A, Khan A, Kerdjoudj M, Jayaraman S. Jayaraman AK, et al. Free Neuropathol. 2020 Jul 14;1:1-19. doi: 10.17879/freeneuropathology-2020-2819. eCollection 2020 Jan. Free Neuropathol. 2020. PMID: 37283668 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases